agilon health (NYSE:AGL) Now Covered by Macquarie

Macquarie initiated coverage on shares of agilon health (NYSE:AGL) in a report published on Monday, MarketBeat reports. The brokerage issued a neutral rating and a $3.00 target price on the stock.

A number of other analysts have also issued reports on the stock. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd. TD Cowen dropped their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 price target on shares of agilon health in a research report on Tuesday, November 19th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. Three analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $4.28.

agilon health Stock Performance

NYSE:AGL opened at $1.95 on Monday. The firm has a 50-day moving average of $2.37 and a two-hundred day moving average of $4.30. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market cap of $803.44 million, a P/E ratio of -2.07 and a beta of 0.51. agilon health has a 1-year low of $1.50 and a 1-year high of $13.45.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the prior year, the company posted ($0.06) EPS. On average, research analysts expect that agilon health will post -0.52 earnings per share for the current fiscal year.

Insider Buying and Selling at agilon health

In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The shares were bought at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the purchase, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 90,000 shares of company stock valued at $198,100 in the last quarter. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently bought and sold shares of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of agilon health in the 3rd quarter valued at approximately $28,000. City State Bank purchased a new stake in shares of agilon health in the third quarter valued at $52,000. CWM LLC boosted its position in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC purchased a new position in shares of agilon health during the second quarter valued at $60,000. Finally, Allspring Global Investments Holdings LLC raised its position in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after buying an additional 10,674 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.